INVESTORS
11 px font size 12 px font size 14 px font size
ASX Announcements
Annual Report
Background Materials
FAQs
Glossary
Corporate Governance
Investor Contact
APOLLO NEWSLETTER
Professor Paul
Zimmet AO
Head of
International Diabetes Institute, Melbourne
"The data that I have seen so far makes this one of the most forward looking and best prospects of an oral insulin"
Click here to see Paul Zimmet's view on Apollo's oral insulin
Bill Moss AM
Non-Executive Director and
Investor
"Apollo has a number of opportunities to grow into the future. Opportunities perhaps that are much greater than many other companies many times their size"
Click here to hear Bill Moss's view on investing in Apollo
Annual Report
 Annual Report 2007
 Annual Report 2006
 Annual Report 2005